Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5960465 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL5960464 | 1.00 | HSP90AA1 (0.35) | — | |
| SCHEMBL4457 | 0.97 | — | — | |
| Phosphine SCHEMBL28646269 | 0.94 | — | — | |
| Fluoride SCHEMBL27615783 | 0.94 | — | — | |
| Water SCHEMBL6720123 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL15169416 | 0.94 | — | — | |
| Benzene SCHEMBL28241501 | 0.92 | NOS2 (0.35) | — | |
| SCHEMBL28245321 | 0.90 | NOS2 (0.33) | — | |
| Formaldehyde SCHEMBL3745727 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955685-A | Pymetrozine artificial antigen and preparation method and application thereof | 泰州市食品检验院 | 2024-11-15 | — | — | CN | disclosed |
| CN-118459712-A | Heat-resistant toughened polyurethane resin and preparation method thereof | 深圳市深赛尔股份有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118459712-A | Heat-resistant toughened polyurethane resin and preparation method thereof | 深圳市深赛尔股份有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-116535515-A | Monoclonal antibody for resisting pymetrozine and application thereof | 武汉上成生物科技有限公司 | 2023-08-04 | — | — | CN | disclosed |
| WO-2023071973-A1 | FUSED BICYCLIC COMPOUND FOR INHIBITING ACTIVITY OF TYROSINE KINASE | SHENZHEN TARGETRX, INC. (CN) | 2023-05-04 | — | — | WO | disclosed |
| EP-2418190-B1 | The method of preparation of enantiomerically enriched products of condensation from racemic acids or acids of the low enentiomeric purity | POLITECHNIKA LODZKA (PL) | 2013-08-28 | — | — | EP | disclosed |
| EP-2407460-B1 | N-TRIAZINYLAMMONIUM SALTS, A METHOD OF PREPARATION AND USES THEREOF | POLITECHNIKA LODZKA (PL) | 2013-07-17 | — | — | EP | disclosed |
| EP-2418190-A1 | The method of preparation of enantiomerically enriched products of condensation from racemic acids or acids of the low enentiomeric purity | Politechnika Lodzka (PL) | 2012-02-15 | — | — | EP | disclosed |
| EP-2407460-A1 | N-Triazinylammonium salts, a method of preparation and uses thereof | Politechnika Lódzka (PL) | 2012-01-18 | — | — | EP | disclosed |
| US-20100292469-A1 | PROCESS FOR THE PREPARATION OF N-TRIAZINYLAMMONIUM SALTS | ITALVELLUTI S.P.A. (IT) | 2010-11-18 | — | — | US | disclosed |
| EP-1586566-B9 | P-toluenosulfonate salt of N-Methyl-N-(3,5-dimathoxy-2,4,6-triazinyl-1-)-morpholine and related compounds for use as condensing reagent in peptide synthesis | POLITECHNIKA LODZKA (PL) | 2009-11-18 | — | — | EP | disclosed |
| EP-1586566-B1 | P-toluenosulfonate salt of N-Methyl-N-(3,5-dimathoxy-2,4,6-triazinyl-1-)-morpholine and related compounds for use as condensing reagent in peptide synthesis | POLITECHNIKA LODZKA (PL) | 2009-05-13 | — | — | EP | disclosed |
| EP-1951691-A1 | PROCESS FOR THE PREPARATION OF N-TRIAZINYLAMMONIUM SALTS | Italvelluti S.p.A. (IT) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007051496-A1 | PROCESS FOR THE PREPARATION OF N-TRIAZINYLAMMONIUM SALTS | ITALVELLUTI S.P.A. (IT) | 2007-05-10 | — | — | WO | disclosed |
| EP-1586566-A1 | P-toluenosulfonate salt of N-Methyl-N-(3,5-dimathoxy-2,4,6-triazinyl-1-)-morpholine and related compounds for use as condensing reagent in peptide synthesis | Politechnika Lodzka (PL) | 2005-10-19 | — | — | EP | disclosed |